Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Endo Pharmaceuticals)"
Count: 131
Selected: 0
| NCT ID | Title |
|---|
| NCT00830154 | A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering | ||
| NCT05419505 | Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks | ||
| NCT05254457 | Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis | ||
| NCT05249257 | Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity | ||
| NCT05152173 | Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis | ||
| NCT04681027 | Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children | ||
| NCT04680156 | Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder) | ||
| NCT04677712 | Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite | ||
| NCT04580303 | CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques | ||
| NCT04496167 | Safety and Efficacy, Using Pain and Function Questionnaires, of EN3835 vs. Placebo in Participants With Frozen Shoulder | ||
| NCT04456296 | A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism | ||
| NCT04381117 | Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH) | ||
| NCT04236635 | Histopathology Following CCH Injection | ||
| NCT04209530 | Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women | ||
| NCT04170296 | Real World CCH Study in Adult Females With Cellulite | ||
| NCT04093050 | Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers | ||
| NCT03893890 | Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | ||
| NCT03675685 | Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP | ||
| NCT03632993 | Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) | ||
| NCT03526549 | Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite) | ||
| NCT03446781 | Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women | ||
| NCT03428750 | Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | ||
| NCT03329989 | Safety and Effectiveness of EN3835 in the Treatment of EFP in Women | ||
| NCT02942160 | EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT02724644 | EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT02687451 | Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | ||
| NCT02298829 | Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease | ||
| NCT02267460 | An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease | ||
| NCT02193828 | Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules | ||
| NCT02006719 | Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT01987986 | A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy | ||
| NCT01774435 | Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant | ||
| NCT01715467 | CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment | ||
| NCT01697384 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | ||
| NCT01685437 | A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease | ||
| NCT01674634 | Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures | ||
| NCT01518907 | The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT01498640 | Retreatment of Recurrent Dupuytren's Contractures | ||
| NCT01483963 | AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT01444729 | Post Approval Commitment Study | ||
| NCT01430169 | Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease | ||
| NCT01407068 | Administration of Two Injections for Multiple Dupuytren's Contractures | ||
| NCT01394263 | Study of Histrelin Subdermal Implant in Patients With Prostate Cancer | ||
| NCT01316874 | Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) | ||
| NCT01314664 | A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) | ||
| NCT01310803 | Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | ||
| NCT01304173 | Retrospective Chart Review of Valstar | ||
| NCT01295060 | Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly | ||
| NCT01243411 | A Study of AA4500 in Men With Peyronie's Disease | ||
| NCT01228071 | Time to Eugonadal Range, Time to Steady State and Drying Time |
